Cramer’s lightning round: AstraZeneca is a pass

Cramer’s lightning round: AstraZeneca is a pass


Intuitive Surgical Inc: “ISRG is one of those stocks – you must not look at it on a day-to-day basis. You look at it on a year-to-year basis, that’s how good their machines are.”

Banco Santander SA: “I looked at it multiple times to own it for the Charitable Trust. I just can’t summon myself to pull the trigger. I’m afraid I’ll move it to $4. I think Banco Santander is excellent.”

Uranium Energy Corp: “Very speculative stock. It’s had a very big run. Be ready to get cut in half or double. And those are typically the kinds of stocks that I do not recommend.”

OneMain Holdings Inc: “Too risky at this point in the cycle, particularly if the Fed really does give us a real slowdown.”

Brunswick Corp: “I’m going to be really straightforward here. The market doesn’t like this stock and doesn’t think it will come back, and I’m trying to disagree with the market, because I think it’s such a good company.”

Regions Financial Corp: “Very smart bank. Very well run … This is a terrific company. Believe me, it won’t stay independent forever it if stays down at this price. It’s just way too good.”

AstraZeneca PLC: “I can’t chase it up here. I think it’s gotten more expensive versus some other very, very good drug companies. So I’m going to have to say that you should take a pass on that.”

Disclosure: Cramer’s Charitable Trust owns shares of Morgan Stanley.



Source

Forgotten no more: Generation X is driving beauty sales
Business

Forgotten no more: Generation X is driving beauty sales

Ryan Mckeever | E+ | Getty Images Move over, Sephora kids. While younger generations have been buying beauty products in droves, data shows that a different generation holds more spending power: Generation X. Often dubbed the “forgotten generation,” Gen X spans those born between 1965 and 1980, according to Pew Research Center. Sandwiched between baby […]

Read More
FDA fast-tracks psychedelic drug research following Trump executive order
Business

FDA fast-tracks psychedelic drug research following Trump executive order

FILE PHOTO: Psilocybin or “magic mushrooms” are seen in an undated photo provided by the U.S. Drug Enforcement Agency (DEA) in Washington, U.S. May 7, 2019. DEA | Reuters The U.S. Food and Drug Administration on Friday announced a series of measures aimed at accelerating the development of psychedelic treatments for serious mental illness. That […]

Read More
New York’s pied-a-terre tax sets up legal fight over values
Business

New York’s pied-a-terre tax sets up legal fight over values

A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. New York’s proposed tax on second homes worth more than $5 million is likely to spark costly legal battles over how to value […]

Read More